The Diagnostic Value of Autoimmune Antibody Detection in Newly Onset and Chronic Epilepsy
NCT ID: NCT04516590
Last Updated: 2020-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
130 participants
OBSERVATIONAL
2020-08-31
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology
NCT06388161
Multicenter and Prospective Clinical Registry Study of Autoimmune Encephalitis in China
NCT02561260
A Multicentric Cohort of Autoimmune Encephalitis
NCT06760091
Predicting and Monitoring Outcomes in Autoimmune Encephalitis
NCT05711563
Risk Prediction Model for Severe Autoimmune Encephalitis
NCT06697678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
autoimmune antigen negative
treated with anti-epilepsy drugs
There was no intervention in this observational study
autoimmune antigen positive
whether the patients receive immune therapy or not will depend on the type and titter of the autoimmune antibody as well as the severity of the symptom
There was no intervention in this observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There was no intervention in this observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 16 to 70 years old
* The etiology of patients with epilepsy is unknown
* The patient or guardian signs an informed consent and can cooperate with the inspection and follow-up for six months
Exclusion Criteria
* The investigation and follow-up cannot be completed due to vision, hearing, language expression, disturbance of consciousness, and impaired understanding, and the guardian cannot replace the completed
* Patients with other progressive or systemic diseases
16 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital of Ningxia Medical University
OTHER
LanZhou University
OTHER
First Affiliated Hospital, Sun Yat-Sen University
OTHER
Henan Provincial People's Hospital
OTHER
The Affiliated Hospital of Inner Mongolia Medical University
OTHER
First Affiliated Hospital of Zhejiang University
OTHER
Wulumuqi General Hospital of Lanzhou Military Command
OTHER
Xuanwu Hospital, Beijing
OTHER
Xiangya Hospital of Central South University
OTHER
West China Hospital
OTHER
Affiliated Hospital of Qinghai University
OTHER
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XijingH Deng Yanchun-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.